Cargando…
Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model
BACKGROUND: The escalating prevalence of type 2 diabetes (T2DM) poses an unparalleled economic catastrophe to developing countries. Cardiovascular diseases remain the primary source of costs among individuals with T2DM, incurring expenses for medications, hospitalizations, and surgical interventions...
Autores principales: | Nogueira, Ana Claudia Cavalcante, Barreto, Joaquim, Moura, Filipe A., Luchiari, Beatriz, Abuhab, Abrão, Bonilha, Isabella, Nadruz, Wilson, Gaziano, J. Michael, Gaziano, Thomas, de Carvalho, Luiz Sergio F., Sposito, Andrei C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599033/ https://www.ncbi.nlm.nih.gov/pubmed/37878108 http://dx.doi.org/10.1186/s13561-023-00466-3 |
Ejemplares similares
-
Very low HDL levels: clinical assessment and management
por: Bonilha, Isabella, et al.
Publicado: (2023) -
The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus
por: Bonilha, Isabella, et al.
Publicado: (2021) -
Glucose-Lowering and the Risk of Cardiovascular Events With Antidiabetic Therapies: A Systematic Review and Additive-Effects Network Meta-Analysis
por: de Carvalho, Luiz Sergio Fernandes, et al.
Publicado: (2022) -
Aspirin in primary prevention and the risk of heart failure: a systematic review and meta‐analysis of controlled trials
por: de Oliveira, Ana Beatrice Magalhães, et al.
Publicado: (2022) -
Compliance with Cardiovascular Prevention Guidelines in Type 2 Diabetes Individuals in a Middle-Income Region: A Cross-Sectional Analysis
por: Barreto, Joaquim, et al.
Publicado: (2022)